Company: BNBX
Filing Date: 2025-11-10
Form Type: DEF 14A
Source: 0001104659-25-109257
Chunk: 35

Company: BNB PLUS CORP.
Filing Date: 2025-11-10
Form: DEF 14A
Chunk 35
---
 ​ |
| Non-Executive Officer Employee Group     | ​ | ​ | ​                | ​ |       — | ​ | ​ | ​ | ​                | ​ | — | ​ | ​ |

* Number of units unknown as of the date hereof. The Board of Directors unanimously recommends a vote “For” the Plan Amendment Proposal.

19

TABLE OF CONTENTS

### EXECUTIVE COMPENSATION

### Compensation Overview
The Compensation Committee has overall responsibility for approving and evaluating the compensation arrangements for our named executive officers. Our named executive officers for fiscal 2025 are:

•

Dr. James Hayward, who served as our Chairman and Chief Executive Officer through June 18, 2025;

•

Judith Murrah, who served as our President, Chief Operating Officer and our Chief Information Officer through June 18, 2025 and then our Chief Executive Officer from June 18, 2025 through September 29, 2025 and our Chairperson from June 18, 2025 to November 6, 2025 and who continues to serve as a director;

•

Clay Shorrock, our Chief Legal Officer, Executive Director of Business Development and President of LineaRx, Inc., our 98% owned subsidiary (“ LRx ”), and then our Chief Executive Officer and President from September 29, 2025; and

•

Beth Jantzen, our Chief Financial Officer.

Our Chairman and Chief Executive Officer, provide recommendations to the Compensation Committee with respect to the compensation of the named executive officers other than for the Chief Executive Officer. However, the Compensation Committee is free to make decisions that are contrary to the Chief Executive Officer’s recommendations.

On June 18, 2025, Dr. Hayward resigned as the Chairman and CEO and Judith Murrah was appointed Chairperson and CEO of the Company. On September 29, 2025, Ms. Murrah resigned as CEO and President of the Company and Clay Shorrock was appointed CEO and President of the Company. On November 6, 2025, Ms. Murrah resigned as Chairperson and Joshua Kruger was appointed as Chairman of the Board and as a director.

Compensation Committee Interlocks and Insider Participation

None of the members of our Compensation Committee is or has been an officer or employee of our Company. None of our executive officers currently serves, or in the past year has served, as a member of the compensation committee or director (or other board committee performing equivalent functions or, in the absence of any such committee, the